Nicole Salazar-Austin1, Silvia Cohn1, Grace Link Barnes1, Molefi Tladi2, Katlego Motlhaoleng2, Catharina Swanepoel3, Zarina Motala3, Ebrahim Variava2,4,5, Neil Martinson1,2, Richard E Chaisson1. 1. Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Perinatal Human Immunodeficiency Virus Research Unit, University of Witwatersrand, Johannesburg. 3. Matlosana Sub-district Department of Health, Klerksdorp/Tshepong Hospital Complex, North West Province Department of Health, Johannesburg, South Africa. 4. Department of Internal Medicine, Klerksdorp/Tshepong Hospital Complex, North West Province Department of Health, Johannesburg, South Africa. 5. University of the Witwatersrand, Johannesburg, South Africa.
Abstract
BACKGROUND:Tuberculosis preventive therapy (TPT) is highly effective at preventing tuberculosis disease in household child contacts (<5 years), but is poorly implemented worldwide. In 2006, the World Health Organization recommended symptom-based screening as a replacement for tuberculin skin testing (TST) to simplify contact evaluation and improve implementation. We aimed to determine the effectiveness of this recommendation. METHODS: We conducted a pragmatic, cluster-randomized trial to determine whether contact evaluation using symptom screening improved the proportion of identified child contacts who initiated TPT, compared to TST-based screening, in Matlosana, South Africa. We randomized 16 clinics to either symptom-based or TST-based contact evaluations. Outcome data were abstracted from customized child contact management files. RESULTS: Contact tracing identified 550 and 467 child contacts in the symptom and TST arms, respectively (0.39 vs 0.32 per case, respectively; P = .27). There was no significant difference by arm in the adjusted proportion of identified child contacts who were screened (52% in symptom arm vs 60% in TST arm; P = .39). The adjusted proportion of identified child contacts who initiated TPT or tuberculosis treatment was 51.5% in the symptom clinics and 57.1% in the TST clinics (difference -5.6%, 95% confidence interval -23.7 to 12.6; P = .52). Based on the district's historic average of 0.7 child contacts per index case, 14% and 15% of child contacts completed 6 months of TPT in the symptom and TST arms, respectively (P = .89). CONCLUSIONS: Symptom-based screening did not improve the proportion of identified child contacts evaluated or initiated on TPT, compared to TST-based screening. Further research is needed to identify bottlenecks and evaluate interventions to ensure all child contacts receive TPT. CLINICAL TRIALS REGISTRATION: NCT03074799.
RCT Entities:
BACKGROUND:Tuberculosis preventive therapy (TPT) is highly effective at preventing tuberculosis disease in household child contacts (<5 years), but is poorly implemented worldwide. In 2006, the World Health Organization recommended symptom-based screening as a replacement for tuberculin skin testing (TST) to simplify contact evaluation and improve implementation. We aimed to determine the effectiveness of this recommendation. METHODS: We conducted a pragmatic, cluster-randomized trial to determine whether contact evaluation using symptom screening improved the proportion of identified child contacts who initiated TPT, compared to TST-based screening, in Matlosana, South Africa. We randomized 16 clinics to either symptom-based or TST-based contact evaluations. Outcome data were abstracted from customized child contact management files. RESULTS: Contact tracing identified 550 and 467 child contacts in the symptom and TST arms, respectively (0.39 vs 0.32 per case, respectively; P = .27). There was no significant difference by arm in the adjusted proportion of identified child contacts who were screened (52% in symptom arm vs 60% in TST arm; P = .39). The adjusted proportion of identified child contacts who initiated TPT or tuberculosis treatment was 51.5% in the symptom clinics and 57.1% in the TST clinics (difference -5.6%, 95% confidence interval -23.7 to 12.6; P = .52). Based on the district's historic average of 0.7 child contacts per index case, 14% and 15% of child contacts completed 6 months of TPT in the symptom and TST arms, respectively (P = .89). CONCLUSIONS: Symptom-based screening did not improve the proportion of identified child contacts evaluated or initiated on TPT, compared to TST-based screening. Further research is needed to identify bottlenecks and evaluate interventions to ensure all child contacts receive TPT. CLINICAL TRIALS REGISTRATION: NCT03074799.
Authors: Leonardo Martinez; Ye Shen; Andreas Handel; Srijita Chakraburty; Catherine M Stein; LaShaunda L Malone; W Henry Boom; Frederick D Quinn; Moses L Joloba; Christopher C Whalen; Sarah Zalwango Journal: Lancet Respir Med Date: 2017-12-19 Impact factor: 30.700
Authors: M Bonnet; C Kyakwera; N Kyomugasho; D Atwine; F Mugabe; M Nansumba; Y Boum Ii; J Mwanga-Amumpaire; J Kiwanuka Journal: Int J Tuberc Lung Dis Date: 2017-08-01 Impact factor: 2.373
Authors: Merrin E Rutherford; Philip C Hill; Rina Triasih; Rebecca Sinfield; Reinout van Crevel; Stephen M Graham Journal: Trop Med Int Health Date: 2012-08-05 Impact factor: 2.622
Authors: Peter J Dodd; Courtney M Yuen; Charalambos Sismanidis; James A Seddon; Helen E Jenkins Journal: Lancet Glob Health Date: 2017-09 Impact factor: 26.763
Authors: James Ayieko; Lisa Abuogi; Brett Simchowitz; Elizabeth A Bukusi; Allan H Smith; Arthur Reingold Journal: BMC Infect Dis Date: 2014-02-20 Impact factor: 3.090
Authors: Daria Szkwarko; Yael Hirsch-Moverman; Lienki Du Plessis; Karen Du Preez; Catherine Carr; Anna M Mandalakas Journal: PLoS One Date: 2017-08-01 Impact factor: 3.240